Pete O'Heeron bought $20k of FBLG
CHIEF EXECUTIVE OFFICER at FibroBiologics, Inc.. 51,500 shares at an average of $0.38, traded Mar 2, 2026, filed Mar 4, 2026.
Score components
- +25RoleCEO
- 0Trade size$20k at market
- -5Relative to holdingsUnder 1% of holdings (0.9%)
- +8Price context70% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -81.6%, 3m -85.8%, 6m -74.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-008903, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | POpen-market purchase Common Stock | +17,428 | $0.35 | $6,152 | 5,924,075 | Mar 4, 2026 |
| Mar 3, 2026 | POpen-market purchase Common Stock | +18,200 | $0.41 | $7,373 | 5,942,275 | Mar 4, 2026 |
| Mar 4, 2026 | POpen-market purchase Common Stock | +15,872 | $0.38 | $6,006 | 5,958,147 | Mar 4, 2026 |
Related signals
Other insiders at FibroBiologics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 48Moderate | FibroBiologics, Inc. | Hamid Khoja Chief Scientific Officer | $11k 30,000 shares | +96% | |
| 58Moderate | FibroBiologics, Inc. | Jason Davis Chief Financial Officer | $29k 70,000 shares | - | |
| 49Moderate | FibroBiologics, Inc. | Ruben A Garcia General Counsel | $13k 40,000 shares | +29% | |
| 30Weak | FBLGbuy FibroBiologics, Inc. | Ruben A Garcia General Counsel | $48k 140,000 shares | - | |
| 25Weak | FBLGbuy FibroBiologics, Inc. | Hamid Khoja Chief Scientific Officer | $17k 20,000 shares | +178% | |
| 51Moderate | FibroBiologics, Inc. | Hamid Khoja Chief Scientific Officer | $19k 10,000 shares | +800% | |
| 41Moderate | FibroBiologics, Inc. | Pete O'Heeron Chief Executive Officer | $16k 8,500 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.